Home › Funds › Velan Capital Investment Management LP › KLRS

Velan Capital Investment Management LP position in KLRS

KALARIS THERAPEUTICS INC · Health Care

Velan Capital Investment Management LP reported holding 25,000 shares of KLRS (KALARIS THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$72K, representing 0.07% of its reported portfolio and ranking #43 among its reported holdings. Velan Capital Investment Management LP has disclosed KLRS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)25.00K sh
Reported value held$72.25K
Portfolio Weight0.07%
First reportedQ1 2026
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Velan Capital Investment Management LP's KLRS position evolved

Velan Capital Investment Management LP first disclosed a stake in KLRS in Q1 2026 at 18,000 shares (US$104K). Across 3 filings, Velan Capital Investment Management LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 25,000 shares valued at US$72K. Notable position changes include a 39% increase in Q2 2026 (shares fell 29% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 18.00K $103.86K New
Q2 2026 25.00K $101.75K Add
Q3 2026 25.00K $72.25K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About KLRS and 13F data

KLRS (KALARIS THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in KLRS — the largest reported positions include Samsara BioCapital, LLC (US$52.4M), WHI TRUST Co LLC (US$282K). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding KLRS

All KLRS fund holders →

FAQ

How long has Velan Capital Investment Management LP held KLRS?

Velan Capital Investment Management LP has disclosed KLRS holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Velan Capital Investment Management LP's current position in KLRS?

As of Q3 2026, Velan Capital Investment Management LP holds 25.00K shares of KLRS (KALARIS THERAPEUTICS INC), valued at $72.25K, representing 0.07% of its reported portfolio and ranking #43.

Has Velan Capital Investment Management LP been buying or selling KLRS?

In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP held unchanged its position in KLRS.

Which other funds hold KLRS?

Other major institutional holders of KLRS include Samsara BioCapital, LLC, WHI TRUST Co LLC, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.